Search Results 71-80 of 16399 for Chronic Lymphocytic Leukemia

  1. Living With Cancer: Diagnosing and treating esophageal cancer - Mayo Clinic News Network

    Chronic lymphocytic leukemia is a type of cancer of the blood and bone marrow — the spongy tissue inside bones where blood cells are made. It most commonly ...

  2. Mayo Clinic Biobank - Cancer

    Chronic lymphocytic leukemia. Asish K. Ghosh, Ph.D., is researching the relationship of microvesicles to chronic lymphocytic leukemia (CLL) development.

  3. A Study of Oral LOXO-305 in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma - Mayo Clinic

    The purpose of this study is to evaluate oral LOXO-305 in patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) or Non-Hodgkin ...

  4. Resources - B-Cell Lymphoproliferative Disorders - Mayo Clinic Research

    Slager's B-Cell Lymphoproliferative Disorders Laboratory, including information about chronic lymphocytic leukemia, lymphoma, multiple myeloma, the National ...

  5. Epidemiology of Monoclonal B-Cell Lymphocytosis Study - B-Cell Lymphoproliferative Disorders - Mayo Clinic Research

    Family history. People with a family history of chronic lymphocytic leukemia are about eight times more likely to develop CLL than are people without a family ...

  6. Acute lymphocytic leukemia - Doctors and departments - Mayo Clinic

    Research. Mayo Clinic physicians collaborate on leukemia care. Mayo Clinic doctors and researchers are studying the latest in diagnosis and treatment of acute ...

  7. A Study of GDC-0199 (ABT-199) Plus MabThera/Rituxan (Rituximab) Compared with Bendamustine Plus MabThera/Rituxan (Rituximab) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia - Mayo Clinic

    Diagnosis of chronic lymphocytic leukemia (CLL) per diagnostic criteria and relapsed or refractory CLL per the iwCLL guidelines. Previously treated with 1-3 ...

  8. A Study to Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia - Mayo Clinic

    ... lymphocytic, or Hodgkin lymphoma) and chronic lymphocytic leukemia. Subject who has high-risk chronic lymphocytic leukemia/small lymphocytic lymphoma.

  9. Ibrutinib (oral route) - Mayo Clinic

    Description. Ibrutinib is used to treat chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), chronic lymphocytic leukemia (CLL)/small ...

  10. Acute lymphocytic leukemia - Doctors and departments - Mayo Clinic

    Research. Mayo Clinic physicians collaborate on leukemia care. Mayo Clinic doctors and researchers are studying the latest in diagnosis and treatment of acute ...